biomaterials

Allevi Author: NJIT Bioprints Vascularized Tissue

NJIT allevi guvendiren vascular vasculature vein 3d bioprint bioprinted bioprinter

We are VERY excited to announce the latest addition the Allevi Author Club; the Guvendiren Lab from the New Jersey Institute of Technology.

Dr. Guvendiren’s lab focuses on creating novel bioinks for tissue engineering and regenerative medicine applications with a focus on 3D bioprinting. Their most recent paper, published in Acta Biomaterialia and titled “3D bioprinting of complex channels within cell-laden hydrogels”, explores their new approach to 3D bioprinting vasculature into 3D tissue.

There are many different methods for creating microchannels within constructs, including electrospinning, fiber bonding, and casting solvents into molds. However these techniques don’t allow for precise control of channel size, shape or location. They can also be time-consuming and restrictive in the number of cell lines that you are able to work with simultaneously.

The Guvendiren lab is exploring a new approach to creating these channel-laden tissues using their Allevi 2 bioprinter. In their paper, they explore a method of 3D bioprinting sacrificial bioinks into cell-laden hydrogels (pluronic into methacrylated alginate/methacrylated hyaluronic acid to be specific). This technique allows them to create custom channel geometries, control channel thickness and tune the hydrogel rigidity. They also explored a super cool technique wherein they alter the printhead speed in order to create channels of differing diameters.

Their images from confocal scanning show strong endothelial cell (HUVEC) attachment to the channel walls and depict the final 3D bioprinted vein construct.

HUVEC vascular channel vein 3d bioprinted bioprint allevi NJIT guvendiren

This research explores important techniques for creating tunable microchannels within 3D tissues. We can imagine a future wherein these methods are used to create 3D bioprinted organs with custom and complex vascular networks. It could also be used to create custom 3D models to study disease progression and test drug efficacy and toxicity. Amazing work, Guvendiren Lab!!

Click through to read their material characterization and learn more about their bioprinting approach: https://www.sciencedirect.com/science/article/pii/S1742706119301515.

Our New Sterile GelMA is Awesome!

Allevi GelMA gelatin methacrylate sterile solution easy to use.JPG

Gelatin Methacrylate (GelMA) is a popular material in bioprinting due to its mechanical properties and printability. However, the process of methacrylating gelatin and sterile filtering it is time-consuming, cumbersome, and inefficient.

We know how annoying it can be! So after months of testing - we're excited to release our new pre-sterilized and pre-loaded GelMA that is ready to be mixed with your cell suspensions and photo-initiators.

No more filtering. No more lost product. No more measuring. Just add your cells and start printing!

We want you to be the first to give it a try!

Allevi Now Available Through VWR

Allevi and VWR logos.png

Here at Allevi, we are constantly working to make our bioprinters and bioinks accessible to scientists worldwide.  Our mission is to get Allevi 3D bioprinters into the best research labs where they can accelerate the pace of discovery and push the boundaries of biology. That's why today we're excited to announce that you can now shop Allevi products on the world's leading life science equipment distributor; VWR International. 

Now it’s easier than ever to get an Allevi bioprinter into your lab and begin changing the world. Join us.

Allevi Author: Plant Based Hydrogels for Cell Laden Bioprinting

plant based hydrogels allevi bioprint.jpg

Time for another inductee to the #AlleviAuthor club. Researchers from University of California, Berkeley and IBM used their Allevi 2 bioprinter to study the printability and viability of plant based bioinks.

In their paper titled, “Agarose-Based Hydrogels as Suitable Bioprinting Materials for Tissue Engineering” and published in ACS Biomaterials Science & Engineering, they compared agarose-based hydrogels commonly used for cartilage tissue engineering to Pluronic. The goal is to find a bioink that has great printability without sacrificing cell viability.

The team compared mechanical and rheological properties, including yield stress, storage modulus, and shear thinning, as well as construct shape fidelity to assess their potential as a bioink for cell-based tissue engineering. Read on to find out which ratios of alginate and agarose demonstrated the best cell viability as well as print structure for their cartilage tissue engineering needs: https://cdn-pubs.acs.org/doi/10.1021/acsbiomaterials.8b00903.

Allevi Author: Lattices vs Sheets for Cardiac Tissue Bioprinting

There are so many variables that go into creating viable 3d bioprinted tissues; bioink selection, print geometry, cure times, rigidity, flexibility, degradation time and cell viability to name a few. Not to mention, each of these parameters needs to be analyzed and perfected for every cell line in the body. As a community, we are still figuring out the perfect protocol for each organ system.

In a new paper out this week titled “A Comparative Study of a 3D Bioprinted Gelatin-Based Lattice and Rectangular-Sheet Structures”, our newest Allevi Authors tackled one of these lingering questions, “What is the best print structure for cardiac tissue, lattice or sheet?”

Researchers at University of Texas El Paso and University of Texas at Austin used their Allevi 2 bioprinter and furfuryl gelatin to study and compare 3d bioprinted lattices vs sheets. Through their comparison, they discovered that the lattice structure was more porous with enhanced rheological properties and exhibited a lower degradation rate compared to the rectangular-sheet.

Further, the lattice allowed cells to proliferate to a greater extent compared to the rectangular-sheet. All of these results collectively affirmed that the lattice poses as a superior scaffold design for tissue engineering applications.

Read the full paper here to learn more about the rigorous testing and analysis the team conducted during their study.